当前位置: X-MOL 学术J. Neuroimmunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Matairesinol ameliorates experimental autoimmune uveitis by suppression of IRBP-specific Th17 cells
Journal of Neuroimmunology ( IF 2.9 ) Pub Date : 2020-08-01 , DOI: 10.1016/j.jneuroim.2020.577286
Xin Li 1 , Qiang Gao 1 , Lei Yang 1 , Meng Han 1 , Chunlei Zhou 1 , Hong Mu 1
Affiliation  

We investigated the effects of matairesinol (MAT) in the experimental autoimmune uveitis (EAU), a classical animal model of uveitis. We found that treatment with MAT could alleviate intraocular inflammation of EAU. Notably, Th17 cells in eyes of EAU mice could be predominantly restrained by MAT. Furthermore, MAT could inhibit Th17 differentiation in vitro. In addition, MAT inhibited the signaling of MAPK and ROR-γt, a pivotal transcription factor for Th17 cell differentiation in vitro and in vivo. Taken together, these results suggested that MAT had immune-suppressive effects on autoimmune inflammation through Th17 cells.

中文翻译:

Matairesinol 通过抑制 IRBP 特异性 Th17 细胞改善实验性自身免疫性葡萄膜炎

我们研究了 matairesinol (MAT) 在实验性自身免疫性葡萄膜炎 (EAU) 中的作用,这是一种经典的葡萄膜炎动物模型。我们发现用 MAT 治疗可以减轻 EAU 的眼内炎症。值得注意的是,EAU 小鼠眼中的 Th17 细胞主要受 MAT 抑制。此外,MAT 可以在体外抑制 Th17 分化。此外,MAT 抑制 MAPK 和 ROR-γt 的信号转导,ROR-γt 是体外和体内 Th17 细胞分化的关键转录因子。总之,这些结果表明 MAT 通过 Th17 细胞对自身免疫性炎症具有免疫抑制作用。
更新日期:2020-08-01
down
wechat
bug